APA (7th ed.) Citation

Peng, W., Chen, R., Dai, H., Zhu, L., Li, Y., Gao, Z., . . . Zhou, S. (2021). Efficacy, Safety, and Tolerability of a Novel Cyclosporine, a Formulation for Dry Eye Disease: A Multicenter Phase II Clinical Study. Clinical therapeutics, 43(3), 613-628. https://doi.org/10.1016/j.clinthera.2020.12.023

Chicago Style (17th ed.) Citation

Peng, Wen-yan, Rong-xin Chen, Hong Dai, Lei Zhu, Ying Li, Zi-qing Gao, Xiao-yi Li, and Shi-you Zhou. "Efficacy, Safety, and Tolerability of a Novel Cyclosporine, a Formulation for Dry Eye Disease: A Multicenter Phase II Clinical Study." Clinical Therapeutics 43, no. 3 (2021): 613-628. https://doi.org/10.1016/j.clinthera.2020.12.023.

MLA (9th ed.) Citation

Peng, Wen-yan, et al. "Efficacy, Safety, and Tolerability of a Novel Cyclosporine, a Formulation for Dry Eye Disease: A Multicenter Phase II Clinical Study." Clinical Therapeutics, vol. 43, no. 3, 2021, pp. 613-628, https://doi.org/10.1016/j.clinthera.2020.12.023.